埃塞俄比亚阿姆哈拉地区麻疹的时间和空间模式,2019-2024年:针对性干预的影响
Demeke Endalamaw1,2, Endalkachew Nibret3,4, Abaineh Munshea3,4
1Health Biotechnology Divisions, Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia. demekeendalamaw@gmail.com.
BMC infectious diseases
|November 6, 2025
概括
麻疹疫情在埃塞俄比亚阿姆哈拉地区持续存在,发病率不断增加,空间和时间模式明确. 针对性的疫苗接种策略对于解决免疫缺口至关重要,特别是在老年儿童和热点地区.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
背景情况:
- 麻疹仍然是埃塞俄比亚,特别是阿姆哈拉地区的重大公共卫生问题,尽管有疫苗接种工作.
- 由于最近流行病学模式,趋势和空间分布的数据有限,定期发生麻疹疫情.
研究的目的:
- 评估2019年至2024年阿姆哈拉地区麻疹病例的发病率,时间趋势和空间聚类.
- 为目标干预提供信息,并改善该地区对麻疹疫情的应对措施.
主要方法:
- 对区域麻疹监测数据 (2019-2024) 的回顾性分析.
- 实验室确认使用酶相关免疫吸收试验 (ELISA) 针对抗麻疹IgM.
- 描述性统计,趋势分析 (SPSS),空间分析 (ArcGIS) 和集群识别 (SaTScan).
主要成果:
- 在18,468个疑似病例中,实验室确诊的麻疹病例为1571.
- 5-14岁儿童 (36.5%) 和男性 (54%) 的发病率最高; 4.7% 不符合疫苗接种条件.
- 越来越多的原油发病率 (0.53到2.13每10万),达到2023年的峰值,季节性峰值在春季和秋季.
- 在Waghimra,奥罗莫特区,南冈达尔和北Shoa地区发现了显著的空间聚类,在woreda级别有热点.
结论:
- 麻疹传播正在阿姆哈拉地区进行,其特点是发病率上升和独特的时空模式.
- 较大的儿童免疫缺口和地理集中的疫情需要加强疫苗接种策略.
- 建议包括加强监测,优先进行追赶疫苗接种,并在高峰季节在热点地区开展有针对性的运动.
相关概念视频
Vaccinations
51.2K
Overview
51.2K
Steps in Outbreak Investigation
476
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
476
Patterns of Fever
3.7K
Before understanding the types and patterns of fever, it is essential to know its phases.
3.7K
Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
Principles of Disease Surveillance
445
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
445


